Formula Grant 2601UTMIDR

This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...

The United States Pharmacopeial Convention, Inc. (USP) received a $100,000 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the Congressional Directives program (CFDA 93.493), awarded on September 22, 2025, with a completion date of September 21, 2026. Under this agreement, USP will develop and complete Medicare Model Guidelines (MMG) Version 10.0, continuing a longstanding collaborative effort mandated by the Medicare Prescription Drug Improvement and...

Grant Award Summary The Department of Health and Human Services Administration for Community Living (ACL) awarded a $1.5 million Cooperative Agreement under CFDA 93.048 (Special Programs for the Aging, Title IV, and Title II, Discretionary Projects) to Northeast Iowa Area Agency On Aging Inc. (doing business as Hawkeye Valley) for the Senior Medicare Patrol Resource Center (SMPRC). The award, effective September 1, 2025, through August 31, 2028, supports the organization's continuation and...

The Department of Health and Human Services Administration for Community Living awarded Mid-America Regional Council Community Services Corporation a $1.199 million cooperative agreement on August 1, 2026, to expand chronic disease self-management education (CDSME) and behavioral health integration across Missouri's Community Integrated Health Network. The recipient will deliver evidence-based CDSME programs to 1,333 participants across nine program models—including Chronic Disease...

The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...

The Department of Health and Human Services Administration for Community Living awarded a cooperative agreement to Monitor My Health Inc. totaling $1,055,671 on August 1, 2026, under the Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs (CFDA 93.734). Monitor My Health Inc., a Connecticut-based 501(c)(3) nonprofit, will expand statewide capacity to deliver the Chronic Disease Self-Management Program (CDSMP/Tomando Control de Su Salud)...

The Department of Health and Human Services Administration for Community Living awarded the Department For Aging And Rehabilitative Services $133,890 on September 1, 2026, under the Medicare Enrollment Assistance Program (CFDA 93.071), a formula grant supporting enhanced outreach to eligible Medicare beneficiaries regarding preventive and wellness benefits, application assistance for individuals eligible for the Low Income Subsidy or Medicare Savings Programs, and disease prevention and wellness...

The National Institute on Aging awarded The Washington University $406,707 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a national longitudinal study examining whether integrated dual-eligible special needs plans improve health outcomes for adults with intellectual disabilities and dementia who are dually enrolled in Medicare and Medicaid. The study addresses the absence of national research on dementia care access, quality, and outcomes among...

The National Institute on Aging awarded the University of Kansas Medical Center Research Institute, Inc. $3,254,395 on July 1, 2026, under the Aging Research program (CFDA 93.866) to implement and evaluate the Brain Health Care Accelerator (BHCA), a clinical and systems intervention designed to improve Alzheimer's disease and related dementias detection in primary care. The BHCA integrates structured cognitive assessments, blood biomarkers including plasma phosphorylated tau-217, electronic...

The National Institutes of Health Office of the Director awarded Ann & Robert H Lurie Children's Hospital of Chicago $448,860 on August 21, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to co-design a digital care pathway that improves primary care clinician adherence to pediatric Down syndrome health supervision guidelines. The project will develop a scalable digital pathway to facilitate clinician implementation of evidence-based Down syndrome screening, early treatment,...